Summary
532.39 -9.47(-1.75%)07/01/2024
Elevance Health Inc (ELV)
Elevance Health Inc (ELV)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -1.75 | 0.33 | 2.25 | 5.53 | 13.18 | 6.75 | 0.00 | 2,327.95 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 532.39 | |
| Open | 541.38 | |
| High | 546.57 | |
| Low | 531.96 | |
| Volume | 303,800 | |
| Change | -9.47 | |
| Change % | -1.75 | |
| Avg Volume (20 Days) | 622,041 | |
| Volume/Avg Volume (20 Days) Ratio | 0.49 | |
| 52 Week Range | 412.00 - 516.38 | |
| Price vs 52 Week High | 3.10% | |
| Price vs 52 Week Low | 29.22% | |
| Range | 0.83 | |
| Gap Up/Down | -2.87 | |
Fundamentals | ||
| Market Capitalization (Mln) | 125,938 | |
| EBIDTA | 10,008,999,936 | |
| PE Ratio | 18.6183 | |
| PEG Ratio | 1.4719 | |
| WallStreet Target Price | 565.23 | |
| Book Value | 149.1870 | |
| Earnings Per Share | 25.4100 | |
| EPS Estimate Current Quarter | 7.8100 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 28.6400 | |
| EPS Estimate Next Year | 32.4700 | |
| Diluted EPS (TTM) | 25.4100 | |
| Revenues | ||
| Profit Marging | 0.0433 | |
| Operating Marging (TTM) | 0.0632 | |
| Return on asset (TTM) | 0.0581 | |
| Return on equity (TTM) | 0.1779 | |
| Revenue TTM | 144,353,001,472 | |
| Revenue per share TTM | 594.2900 | |
| Quarterly Revenue Growth (YOY) | 0.1760 | |
| Quarterly Earnings Growth (YOY) | 0.1010 | |
| Gross Profit (TTM) | 35,998,000,000 | |
| Dividends | ||
| Dividend Share | 4.6700 | |
| Dividend Yield | 0.0108 | |
| Valuations | ||
| Trailing PE | 18.6183 | |
| Forward PE | 16.8919 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 3.2340 | |
| Revenue Enterprise Value | 0.9244 | |
| EBITDA Enterprise Value | 0.0000 | |
| Shares | ||
| Shares Outstanding | 241,084,992 | |
| Shares Float | 240,641,184 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.19 | |
| Institutions (%) | 93.43 | |
06/28 10:45 EST - zacks.com
Why Elevance Health (ELV) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Elevance Health (ELV) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
06/26 16:05 EST - businesswire.com
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access Code - 3972058 (Domestic) 312-470-0178 – Access Code - 3972058 (International) 800-39.
Elevance Health to Hold Conference Call and Webcast to Discuss Second Quarter 2024 Results on July 17, 2024
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release second quarter 2024 financial results on July 17, 2024, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access Code - 3972058 (Domestic) 312-470-0178 – Access Code - 3972058 (International) 800-39.
06/24 13:45 EST - benzinga.com
Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued
Morgan Stanley has initiated coverage on Elevance Health Inc ELV, an American health insurance provider formerly Anthem Inc, citing compelling risk-reward.
Morgan Stanley Says Elevance Health's Growth Attributed To Consistent Performance But Undervalued
Morgan Stanley has initiated coverage on Elevance Health Inc ELV, an American health insurance provider formerly Anthem Inc, citing compelling risk-reward.
06/23 10:25 EST - investorplace.com
The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector's strength is driven by an aging global population, rising healthcare expenditures, and advancements in medical technology.
The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
The healthcare sector is often considered a defensive play, with healthcare stocks to buy offering stability and growth potential even during economic downturns. The sector's strength is driven by an aging global population, rising healthcare expenditures, and advancements in medical technology.
06/20 13:26 EST - zacks.com
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.
Elevance Health (ELV) Rallies 11.8% YTD: More Room to Run?
Elevance Health's (ELV) performance benefits from new contract wins, a strong Carelon segment and recovering Medicaid business.
06/19 15:25 EST - investorplace.com
3 Healthcare Stocks to Buy as Medicare Goes Private
While it's never a bad time to look for healthcare stocks to buy, the privatization of Medicare has created some very prosperous businesses. As a result, it's not necessarily great for consumers.
3 Healthcare Stocks to Buy as Medicare Goes Private
While it's never a bad time to look for healthcare stocks to buy, the privatization of Medicare has created some very prosperous businesses. As a result, it's not necessarily great for consumers.
06/14 11:00 EST - investorplace.com
Bullish Bets: 3 Stocks Getting the Green Light From Wall Street
Wall Street analysts have recently greenlit several stocks to buy. Despite their mixed reputation, the truth is that not everyone can accurately predict bearish or bullish bets.
Bullish Bets: 3 Stocks Getting the Green Light From Wall Street
Wall Street analysts have recently greenlit several stocks to buy. Despite their mixed reputation, the truth is that not everyone can accurately predict bearish or bullish bets.
06/13 11:19 EST - zacks.com
Here's Why Elevance Health (ELV) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Elevance Health (ELV) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
06/12 14:19 EST - reuters.com
Elevance exec says Medicaid attrition has changed mix of members
Elevance Health executive Peter Haytaian said on Wednesday that a decrease in the number of people eligible for its Medicaid plans this year, as well as changes the company made in where it operates those plans, shifted its balance of healthy and sick members.
Elevance exec says Medicaid attrition has changed mix of members
Elevance Health executive Peter Haytaian said on Wednesday that a decrease in the number of people eligible for its Medicaid plans this year, as well as changes the company made in where it operates those plans, shifted its balance of healthy and sick members.
06/12 10:41 EST - zacks.com
Here's Why Elevance Health (ELV) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Elevance Health (ELV) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
06/09 10:30 EST - 247wallst.com
10 Smartest Dividend Stocks to Buy With $500 Right Now
There are several different strategies for investing in the stock market, one of which is investing to maximize dividends.
10 Smartest Dividend Stocks to Buy With $500 Right Now
There are several different strategies for investing in the stock market, one of which is investing to maximize dividends.
06/04 09:00 EST - businesswire.com
Elevance Health Foundation Exceeds $30 Million Milestone With Substance Use Disorder Programs Through Third Phase of Grants
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces the expansion of its substance use disorder (SUD) grants through an additional $13.1 million in awards across 35 nonprofit organizations. Each program will address substance use disorder, focusing on improving access to care, quality of treatment, and youth prevention and early intervention. This third phase of grants is part of the three-year, $30 million commitment the Foundati.
Elevance Health Foundation Exceeds $30 Million Milestone With Substance Use Disorder Programs Through Third Phase of Grants
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health Foundation, the philanthropic arm of Elevance Health, today announces the expansion of its substance use disorder (SUD) grants through an additional $13.1 million in awards across 35 nonprofit organizations. Each program will address substance use disorder, focusing on improving access to care, quality of treatment, and youth prevention and early intervention. This third phase of grants is part of the three-year, $30 million commitment the Foundati.
06/03 12:25 EST - zacks.com
Elevance Health (ELV) Stock Jumps 6.1%: Will It Continue to Soar?
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Elevance Health (ELV) Stock Jumps 6.1%: Will It Continue to Soar?
Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
06/03 11:46 EST - seekingalpha.com
My Top 15 High Growth Dividend Stocks For June 2024
The SPDR S&P 500 ETF Trust had a 5.06% gain in May, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares, +3.33%. The top 15 dividend growth stocks for June 2024 offer an average dividend yield of 1.37% and appear to be about 28% undervalued based on dividend yield theory. Since its inception in September 2020, the watchlist has achieved an 11.12% annualized return, beating VIG by 0.10% but trailing SPY by 2.18%.
My Top 15 High Growth Dividend Stocks For June 2024
The SPDR S&P 500 ETF Trust had a 5.06% gain in May, outperforming Vanguard's Dividend Appreciation Index Fund ETF Shares, +3.33%. The top 15 dividend growth stocks for June 2024 offer an average dividend yield of 1.37% and appear to be about 28% undervalued based on dividend yield theory. Since its inception in September 2020, the watchlist has achieved an 11.12% annualized return, beating VIG by 0.10% but trailing SPY by 2.18%.
05/30 16:05 EST - businesswire.com
Elevance Health Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those unable to listen to the live webcast, a rep.
Elevance Health Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that senior management is scheduled to present at Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, Florida on June 12 at 1:20 p.m. Eastern Daylight Time (EDT). All interested parties are invited to listen to a live webcast of the presentation by visiting www.elevancehealth.com and selecting the “Investors” link. You may also access the link here. For those unable to listen to the live webcast, a rep.
05/29 13:35 EST - reuters.com
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
Shares of U.S. health insurers fell on Wednesday after UnitedHealth Group cited a near-term disturbance around reimbursement rates for Medicaid due to ongoing program-wide enrollment hurdles that began about a year ago.
US health insurer shares fall after UnitedHealth flags Medicaid enrollment issues
Shares of U.S. health insurers fell on Wednesday after UnitedHealth Group cited a near-term disturbance around reimbursement rates for Medicaid due to ongoing program-wide enrollment hurdles that began about a year ago.
05/28 10:46 EST - zacks.com
Why Elevance Health (ELV) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Elevance Health (ELV) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
05/22 10:15 EST - businesswire.com
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc.'s New Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned the Long-Term Issue Credit Ratings of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $600 million, 5.15% senior unsecured notes, due 2029; $1 billion, 5.375% senior unsecured notes, due 2034 and $1 billion, 5.65% senior unsecured notes, due 2054. The outlook assigned to these Credit Ratings (ratings) is stable. The proceeds from these issues are expected to be used for general corporate purposes, in.
AM Best Assigns Issue Credit Ratings to Elevance Health, Inc.'s New Senior Unsecured Notes
OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has assigned the Long-Term Issue Credit Ratings of “bbb+” (Good) to Elevance Health, Inc.'s (Elevance Health) (Indianapolis, IN) newly issued $600 million, 5.15% senior unsecured notes, due 2029; $1 billion, 5.375% senior unsecured notes, due 2034 and $1 billion, 5.65% senior unsecured notes, due 2054. The outlook assigned to these Credit Ratings (ratings) is stable. The proceeds from these issues are expected to be used for general corporate purposes, in.
05/21 13:40 EST - zacks.com
Elevance (ELV) Rises 14.9% YTD: What Lies Ahead for Investors?
Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.
Elevance (ELV) Rises 14.9% YTD: What Lies Ahead for Investors?
Elevance (ELV) continues to focus on increasing shareholder value with consistent dividend payouts and stock repurchases.